Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Experimental Physiology|February 15, 2011
Relationship between force and size in human single muscle fibresLisa S Krivickas, David J Dorer, Julien Ochala, et al.
Psychotherapy and Psychosomatics|April 23, 2003
The problem of the placebo response in clinical trials for psychiatric disorders: culprits, possible remedies, and a novel study design approachMaurizio Fava, A Eden Evins, David J Dorer, et al.
Pflugers Archiv : European Journal of Physiology|April 20, 2006
Single skeletal muscle fiber behavior after a quick stretch in young and older men: a possible explanation of the relative preservation of eccentric force in old ageJulien Ochala, David J Dorer, Walter R Frontera, et al.
Neurology|July 27, 2005
Infantile spasms and intellectual outcomes in children with tuberous sclerosis complexSuzanne Goh, David J Kwiatkowski, David J Dorer, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|May 11, 2007
Economic evaluation of interactive teledermatology compared with conventional careApril W Armstrong, David J Dorer, Nancy E Lugn, et al.
Pediatrics|August 3, 2004
Clinical outcomes of near-term infantsMarvin L Wang, David J Dorer, Michael P Fleming, et al.
Journal of Clinical Pharmacology|June 27, 2013
Effects of ketoconazole on the pharmacokinetics of ponatinib in healthy subjectsNarayana I Narasimhan, David J Dorer, Katie Niland, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|November 24, 2006
The educational impact of ACGME limits on resident and fellow duty hours: a pre-post survey studyReshma Jagsi, Jo Shapiro, Joel S Weissman, et al.
Clinical Drug Investigation|August 23, 2014
Evaluation of the effect of multiple doses of lansoprazole on the pharmacokinetics and safety of ponatinib in healthy subjectsNarayana I Narasimhan, David J Dorer, Jeffrey Davis, et al.
Clinical Pharmacology in Drug Development|May 4, 2016
Evaluation of the effect of multiple doses of rifampin on the pharmacokinetics and safety of ponatinib in healthy subjectsNarayana I Narasimhan, David J Dorer, Jeffrey Davis, et al.
Pageof 4